전일 마감가:
$64.54
열려 있는:
$64.67
하루 거래량:
2.85M
Relative Volume:
0.68
시가총액:
$32.29B
수익:
$198.10B
순이익/손실:
$-6.45B
주가수익비율:
-4.9725
EPS:
-13.1443
순현금흐름:
$7.11B
1주 성능:
+3.76%
1개월 성능:
+2.03%
6개월 성능:
+74.06%
1년 성능:
+72.77%
센텐 Stock (CNC) Company Profile
명칭
Centene Corp
전화
(314) 725-4477
주소
7700 FORSYTH BLVD., ST LOUIS
Compare CNC vs UNH, CVS, ELV, CI, HUM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
CNC
Centene Corp
|
65.36 | 32.29B | 198.10B | -6.45B | 7.11B | -13.14 |
|
UNH
Unitedhealth Group Inc
|
379.30 | 340.46B | 450.13B | 14.91B | 23.62B | 15.55 |
|
CVS
Cvs Health Corp
|
86.16 | 110.20B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
ELV
Elevance Health Inc
|
412.70 | 89.50B | 201.11B | 4.95B | 6.29B | 22.50 |
|
CI
Cigna Group
|
282.43 | 74.63B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
431.87 | 51.86B | 137.20B | 1.15B | 1.27B | 9.3439 |
센텐 Stock (CNC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-08-11 | 업그레이드 | Argus | Hold → Buy |
| 2026-06-23 | 개시 | RBC Capital Mkts | Sector Perform |
| 2026-05-20 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-04-29 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2026-04-29 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2026-01-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-10-14 | 개시 | Goldman | Sell |
| 2025-07-28 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-23 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-07-21 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-07-16 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2025-07-10 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-07-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-06-09 | 재개 | Morgan Stanley | Overweight |
| 2025-06-02 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-04-08 | 업그레이드 | Jefferies | Underperform → Hold |
| 2025-02-06 | 다운그레이드 | Argus | Buy → Hold |
| 2024-12-17 | 재개 | JP Morgan | Overweight |
| 2024-12-13 | 업그레이드 | UBS | Neutral → Buy |
| 2024-12-10 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2024-07-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-05-30 | 개시 | Robert W. Baird | Neutral |
| 2024-03-21 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-03-06 | 개시 | Barclays | Overweight |
| 2024-01-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-09-05 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-08-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-06-20 | 개시 | UBS | Neutral |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-03-08 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-02-23 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-13 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-09-30 | 개시 | Argus | Buy |
| 2022-08-26 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-07-28 | 재개 | Barclays | Overweight |
| 2022-07-14 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-06-21 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2022-06-17 | 개시 | Loop Capital | Buy |
| 2022-05-27 | 재개 | Bernstein | Outperform |
| 2022-05-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-01-07 | 재개 | Barclays | Overweight |
| 2022-01-06 | 재개 | JP Morgan | Overweight |
| 2021-12-14 | 개시 | Goldman | Neutral |
| 2021-12-13 | 재확인 | BMO Capital Markets | Outperform |
| 2021-12-13 | 재확인 | BofA Securities | Buy |
| 2021-12-13 | 재확인 | Credit Suisse | Neutral |
| 2021-12-13 | 재확인 | Mizuho | Neutral |
| 2021-12-13 | 재확인 | Oppenheimer | Outperform |
| 2021-12-13 | 재확인 | Stephens | Overweight |
| 2021-12-13 | 재확인 | Truist | Buy |
| 2021-12-13 | 재확인 | Wells Fargo | Overweight |
| 2021-12-13 | 재확인 | Wolfe Research | Outperform |
| 2021-11-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-09-10 | 개시 | Cowen | Outperform |
| 2021-07-09 | 개시 | Seaport Global Securities | Buy |
| 2021-05-19 | 개시 | Wells Fargo | Overweight |
| 2021-05-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-03-10 | 개시 | Mizuho | Neutral |
| 2021-01-21 | 재개 | Goldman | Neutral |
| 2021-01-15 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-09-22 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | 개시 | SVB Leerink | Outperform |
| 2020-02-05 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-02-03 | 재개 | Evercore ISI | Outperform |
| 2020-01-28 | 재확인 | Bernstein | Outperform |
| 2020-01-06 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Buy |
| 2019-05-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-01-14 | 개시 | Stephens | Overweight |
| 2018-10-24 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-07-18 | 재개 | Citigroup | Neutral |
| 2017-12-18 | 재확인 | Jefferies | Buy |
| 2017-09-13 | 재확인 | Leerink Partners | Mkt Perform |
| 2017-06-07 | 개시 | Morgan Stanley | Overweight |
| 2017-05-22 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-04-05 | 개시 | Deutsche Bank | Buy |
| 2017-03-23 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2017-02-08 | 재확인 | Barclays | Overweight |
| 2017-02-07 | 재개 | Cantor Fitzgerald | Overweight |
| 2017-01-04 | 개시 | Piper Jaffray | Overweight |
모두보기
센텐 주식(CNC)의 최신 뉴스
Can Oscar Health Turn ACA Marketplace Growth Into Lasting Profits? - Zacks Investment Research
Centene Corp To Redeem $568.66 Mln Of 4.25% Notes Due 2027 On Oct 23, 2026 - TradingView
NH Healthy Families Earns a 4.0 out of 5-Star NCQA Medicaid Health Plan Rating - Centene Corporation
Centene to redeem $568.7M of 4.25% notes due 2027 on Oct. 23 - TradingView
Earnings Preview: What to Expect From Centene's Report - Barchart.com
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy? - Zacks Investment Research
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy? - Zacks Investment Research
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy? - Yahoo Finance
Centene to Offer Expanded Health Access to Eligible Ambetter Members - www.marketscreener.com
Ambetter Health Solutions and Marathon Health Expand Access to Primary Care for Members in Indiana and Missouri - PR Newswire
Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated - Zacks Investment Research
Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated - Yahoo Finance
Buy 5 Growth Stocks to Boost Your Portfolio in Q4 After a Mixed Q3 - Zacks Investment Research
Centene Corp (XBUL:QEN) Stock Price, Trades & News - GuruFocus
Oscar Health Trading at a Premium: Why Should You Still Buy It? - Zacks Investment Research
Centene Corp. stock gains 1.11 percent ahead of Q3 results - AD HOC NEWS
Centene reaffirms 2026 earnings guidance: Centene stock gains 1.68 percent - AD HOC NEWS
Are Investors Undervaluing Centene (CNC) Right Now? - Zacks Investment Research
Are Investors Undervaluing Centene (CNC) Right Now? - Yahoo Finance UK
Are Investors Undervaluing Centene (CNC) Right Now? - Yahoo Finance
Centene Corp (CNC) Stock Up 3.3% and Still Undervalued -- GF Sco - GuruFocus
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
Centene stock after-hours at EUR 55.62: plus 2.53 percent - AD HOC NEWS
Centene Corporation (CNC) - Yahoo! Finance Canada
Vance's fraud crackdown may raise costs for US health insurers, enrollees - marketscreener.com
Centene Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Centene Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Centene (CNC): Pricing Actions and Profit Stabilization Drive Earnings Recovery - Yahoo Finance
Centene Corporation (CNC) Jumped on Beat-and-Raise Earnings Quarter - Yahoo Finance
Cantor Fitzgerald reiterates Centene stock rating on margin recovery - Investing.com
Best Growth Stocks to Buy for October 1st - Zacks Investment Research
Zacks.com featured highlights include Banco Macro, Centene, Enersys, Gibraltar Industries and Kennametal - Zacks Investment Research
Zacks.com featured highlights include Banco Macro, Centene, Enersys, Gibraltar Industries and Kennametal - Yahoo Finance
A 583-share award at $0 goes to Centene (CNC) director Theodore R. Samuels II. - Stock Titan
After a 603-share grant, Centene (CNC) director Kenneth Tanji holds 13,093 shares. - Stock Titan
A director received 864 shares at Centene (CNC) on September 30, 2026. - Stock Titan
5 Low P/B Stocks With Attractive Value and Strong Growth Potential - Zacks Investment Research
Centene Corporation Cash Flow – HAN:QEN - TradingView
Centene stock: Company reaffirms 2026 EPS guidance - ad-hoc-news.de
Best Growth Stocks to Buy for September 29th - Zacks Investment Research
Best Growth Stocks to Buy for September 29th - Yahoo Finance UK
(CNC) Risk Channels and Responsive Allocation - Stock Traders Daily
Centene stock gains 1.08 percent as EPS guidance holds - AD HOC NEWS
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
Centene Corporation stock last trades at USD 62.38 on September 28, 2026 - AD HOC NEWS
Centene Corporation (CNC) options chain - Yahoo Finance UK
Centene Corp Lobbying Profile, 2023 - OpenSecrets
Centene Insiders Sell US$15m Of Stock, Possibly Signalling Caution - Moomoo
Centene (CNC) Q1 2026 Earnings Call Transcript - Fortune
센텐 (CNC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
센텐 주식 (CNC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| KOSTER CHRISTOPHER | Officer |
Aug 26 '26 |
Proposed Sale |
66.90 |
56,500 |
3,779,852 |
0 |
| Burdick Kenneth A | Former Director |
Aug 26 '26 |
Proposed Sale |
65.00 |
43,600 |
2,834,000 |
0 |
| KOSTER CHRISTOPHER | Secretary & General Counsel |
Aug 18 '26 |
Sale |
65.36 |
47,603 |
3,111,332 |
305,354 |
| KOSTER CHRISTOPHER | Officer |
Aug 18 '26 |
Proposed Sale |
65.36 |
47,603 |
3,111,262 |
0 |
| Burdick Kenneth A | Former Director |
Aug 05 '26 |
Proposed Sale |
68.15 |
100,000 |
6,815,182 |
0 |
| Burdick Kenneth A | Director |
Jun 10 '26 |
Proposed Sale |
64.55 |
80,000 |
5,164,227 |
0 |
| Burdick Kenneth A | Director |
Jun 10 '26 |
Sale |
64.55 |
80,000 |
5,164,000 |
197,086 |
| Burdick Kenneth A | Director |
Dec 04 '25 |
Sale |
39.00 |
32,796 |
1,279,044 |
272,365 |
| Burdick Kenneth A | Director |
Dec 04 '25 |
Proposed Sale |
39.00 |
32,796 |
1,279,044 |
0 |
| Burdick Kenneth A | Director |
Dec 03 '25 |
Sale |
39.04 |
33,211 |
1,296,557 |
305,161 |
자본화:
|
볼륨(24시간):